NPPB and neoplasm: This study aimed to evaluate the predictive accuracy of NT-proBNP as a cardiac biomarker for prognosis and risk of complications, such as early mortality (≤ 30 days), late mortality (> 30 days), and recurrence of PE, in relation to the location and stage of associated neoplasms.